Blood as a window to our health
We have been understanding our health through a number of blood tests in a large spectrum of scenarios; ranging from diabetes to heart attack, from pregnancy to cancer. We track proteins, circulating DNA, miRNA, etc
We have been understanding our health through a number of blood tests in a large spectrum of scenarios; ranging from diabetes to heart attack, from pregnancy to cancer. We track proteins, circulating DNA, miRNA, etc
With the advancement of technology, we can now capture and digitize analytes in our blood quantitatively. AccuScan is the whole genome sequencing technology we built with many years of efforts to accurately convert signals from circulating tumor DNA to infer tumor load of an individual.
By gathering multi-omics information from a large population of healthy and cancer cohort, we train with the state-of-the-art machine learning algorithm to differentiate cancer and healthy status of an individual.
The potential applications of liquid biopsy are vast - from targeted cancer therapy selection to real-time minimal residual disease monitoring to population-level early screening - and we believe it will play a critical role in the future of cancer management. With more clinical studies that we're collecting, we will show clincal utility for different applications. For the next person coming to our clinic, we will take a snapshot with his blood and try to catch cancer in a stage that can be treated.